ArticleVemurafenib-Induced Plantar HyperkeratosisAuthor:Paul M. Bedocs Publish date: September 27, 2018Vemurafenib, a selective BRAF inhibitor, is a chemotherapeutic agent used in the treatment of metastatic melanoma with BRAF mutations. It has been ... Read More
